johnson and johnson glp-1

johnson and johnson glp-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1 J&J avoiding GLP-1 space to

Name: johnson and johnson glp-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1 J&J avoiding GLP-1 space to
Brand: inmobiliariafranchi.com
SKU: 84887362906
Price: 24.45 USD
Availability: InStock
Rating: 4.7038 (16 reviews)

SKU: 84887362906

4.7

USD24.45 USD61.45

Pay in 4 interest-free payments of $6.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Description

Would you like a signed copy of the book, with a personal message

The efficacy and safety profiles of these medications elevate their value in treating diabetes, thus driving market share within this therapeutic area